All eyes on antitrust enforcement in China's pharmaceutical industry
July 2016Competition Policy International (CPI) Antitrust Chronicle
All three Chinese antitrust authorities have been involved, and all types of anti-competitive conduct have been targeted. The multiple actions described above put the pharmaceutical sector very clearly into the spotlight. Very few other sectors have seen the same level of antitrust enforcement activism in recent months, and there does not seem to be an end in sight to this activism."
Read the full article here.